Unresolved Issues in Evaluation and Treatment of Preexcitation Syndromes

  • David G. Benditt
  • D. Woodrow Benson


The preexcitation syndromes have been the subject of extensive study, particularly during the last two decades. As a result, we have derived an understanding of both the anatomic substrates of the syndromes and the pathophysiology of its related tachyarrhythmias which far exceeds that of any other disorder associated with cardiac rhythm disturbances. Further, techniques for the precise analysis of the rhythm disorders associated with the preexcitation syndromes have been developed, and a relatively extensive medical and surgical armamentarium for treatment and in some instances of apparent cure of the underlying problem has resulted. Nonetheless, many aspects of the preexcitation syndromes remain to be explored and clarified. The purpose of this chapter is to highlight certain elements of these syndromes in which the final word is not yet in. The list is certainly not comprehensive. However, we hope that it will provide a stimulus for further study of a number of clinically pertinent issues, ultimately leading to both greater insight into these syndromes on the part of interested physicians and scientists and better treatment for patients.


Atrial Fibrillation Antiarrhythmic Drug Accessory Pathway Effective Refractory Period Versus Connection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gettes LS, Zipes DP, Gillette PC, Josephson ME, Laks MM, Mirvis DM, Scheinman MM, Sheffield LT, Wu D: Personnel and equipment required for electrophysiologic testing. Report of the committee on electrocardiography and cardiac electrophysiology, council on clinical cardiology, The American Heart Association. Circulation 69: 1219A, 1984.Google Scholar
  2. 2.
    Gallagher JJ, Gilbert M, Svenson RH, Sealy WC, Kasell J, Wallace AG: Wolff-Parkinson-White syndrome. The problem, evaluation, and surgical correction. Circulation 51: 767, 1975.PubMedGoogle Scholar
  3. 3.
    Gallagher JJ, Pritchett ELC, Sealy WC, Kasell J, Wallace AG: The preexciation syndromes. Prog. Cardiovasc. Dis. 20: 285, 1978.PubMedCrossRefGoogle Scholar
  4. 4.
    Prystowsky EN, Miles WM, Heger JJ, Zipes DP: Preexcitation syndromes. Mechanisms and management. Med. Clin. N. 68: 831, 1984.Google Scholar
  5. 5.
    5.Lévy S, Broustet J-P, Clementy J, Vircoulon B, Bricaud H, Gerard R: Value of noninvasive techniques in the Wolff-Parkinson-White syndrome with particular reference to exercise testing. In Cardiac Arrhythmias: From Diagnosis to Treatment. Lévy S, Scheinman MM, (eds.). Futura, Mont Kisco, 1984, pp. 301–312.Google Scholar
  6. 6.
    German LD, Gallagher JJ, Broughton A, Guarnieri T, Trantham JL: Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Am. J. Cardiol. 51: 1203, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Wellens HJJ, Brugada P, Roy D, Weiss J, Bar FW: Effect of isoproterenol on the antegrade refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am. J. Cardiol. 50: 180, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Tonkin AM, Miller HC, Svenson RH, Wallace AG, Gallagher JJ: Refractory periods of the accessory pathway in the Wolff-ParkinsonWhite syndrome. Circulation 52: 563, 1975.PubMedGoogle Scholar
  9. 9.
    Wellens HJJ, Bar FW, Dassen WRM, Brugada P, Vanagt EJ, Farre J: Effect of drugs in the WolffParkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway. Am. J. Cardiol. 46: 665, 1980.PubMedCrossRefGoogle Scholar
  10. 10.
    Akhtar M, Gilbert CJ, Shenasa M: Effect of lidocaine on atrioventricular response via the accessory pathway in patients with WolffParkinson-White syndrome. Circulation 63: 435, 1981.PubMedCrossRefGoogle Scholar
  11. 11.
    Wells JL, Karp RB, Kouchoukos NT, Maclean WAH, James TN, Waldo AL: Characterization of atrial fibrillation in man: Studies following open heart surgery. PACE 1: 426, 1978.Google Scholar
  12. 12.
    Klein GJ, Bashore TM, Sellers TD, Pritchett ELC, Smith WM, Gallagher JJ: Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N. Engl. J. Med. 301: 1080, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Pritchett ELC, Hammill SC, Reiter MJ, Lee KL, McCarthy EA, Zimmerman JM, Shand DG: Life table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal tachycardias. Am. J. Cardiol. 52: 1007, 1983.PubMedCrossRefGoogle Scholar
  14. 15.
    Sellers TD Jr, Bashore TM, Gallagher JJ: Digitalis in the preexcitation syndrome: Analysis during atrial fibrillation. Circulation 56: 260, 1977.PubMedGoogle Scholar
  15. 16.
    Spurrell RAJ, Krikler DM, Sowton E: Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in WolffParkinson-White syndrome. Br. Heart J. 36: 256, 1974.PubMedCrossRefGoogle Scholar
  16. 17.
    Gulamhusein S, Ko P, Carruthers SG, Klein GJ: Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation 65: 348, 1982.PubMedCrossRefGoogle Scholar
  17. 18.
    Petri H, Kafka W, Hall D, Rudolph W: Potential acceleration of the ventricular rate in WolffParkinson-White syndrome with atrial fibrillation after verapamil. (Abstract.) Circulation 62 (Supp II): 262, 1980.Google Scholar
  18. 19.
    Gallagher JJ, Sealy WC, Cox JL, Kasell JH: Results of surgery for preexcitation in 200 con-552 VI. FUTURE PROSPECTS secutive cases. In Cardiac Arrhythmias: From Diagnosis to Therapy. Lévy S, Scheinman MM, (eds.). Futura, Mount Kisco, 1984, pp. 323–340.Google Scholar
  19. 20.
    Benson DW, Jr, Dunnigan A, Green TP, Benditt DG, Schneider SP: Periodic procainamide for paroxysmal tachycardia. Circulation 72: 147, 1985.PubMedCrossRefGoogle Scholar
  20. 21.
    Kugler JD, Gillette PC, Duff DF, Cooley DA, McNamara DG: Elective mapping and surgical division of the bundle of Kent in a patient with Ebstein’s anomaly who required tricuspid valve replacement. Am. J. Cardiol. 41: 602, 1978.PubMedCrossRefGoogle Scholar
  21. 22.
    Mantakas ME, McCue CM, Miller WM: Natural history of Wolff-Parkinson-White syndrome discovered in infancy. Am. J. Cardiol. 41: 1097, 1978.PubMedCrossRefGoogle Scholar
  22. 23.
    Scheinman MM, Davis JC: Catheter ablation for treatment of tachyarrhythmias: present role and potential promise. Circulation 73: 10, 1986.PubMedCrossRefGoogle Scholar
  23. 24.
    Waldo AL, Plumb VJ, Arciniegas JG, MacLean WAH, Cooper TB, Priest MF, James TN: Transient entrainment and interruption of the atrioventricular bypass pathway type of paroxysmal atrial tachycardia. A model for understanding and identifying reentrant arrhythmias. Circulation 67: 73, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing 1986

Authors and Affiliations

  • David G. Benditt
  • D. Woodrow Benson

There are no affiliations available

Personalised recommendations